On December 30, 2021, KoBioLabs, Inc closed the transaction. The company has received KRW 2,350,000,000 in its second tranche bringing the total funds raised in the transaction to KRW 6,999,997,750.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,825 KRW | +0.31% | +8.31% | -21.42% |
1st Jan change | Capi. | |
---|---|---|
-21.42% | 63.28M | |
+31.41% | 12.02B | |
+15.48% | 3.06B | |
-8.46% | 1.23B | |
+1.77% | 658M | |
+45.05% | 617M | |
+2.03% | 615M | |
-4.17% | 495M | |
+30.43% | 473M | |
+3.90% | 306M |
- Stock Market
- Equities
- A330730 Stock
- News Stonebridge Ventures Inc.
- KoBioLabs, Inc announced that it has received KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors